| 0700 – 0745 |
Registration/Breakfast |
| 0745 – 0800 |
Opening Remarks |
Session 1: Combined Neuro/ Plastics – How to manage challenging inflammatory disorders?
|
|
| 0800 – 0815 |
Unusual manifestations of cavernous sinus disorders |
| 0815 – 0830 |
Orbital cellulitis – Approach and management |
| 0830 – 0845 |
Orbital inflammatory syndrome and Tolosa Hunt Syndrome |
| 0845 – 0900 |
TED – approach to diagnosis |
| 0900 – 0910 |
Epiphora, nasolacrimal duct obstruction and dacryocystitis |
| 0910 – 0920 |
Cavernous Sinus Thrombosis |
| 0920 – 0935 |
Session 1 – Q&A |
| 0935 – 1005 |
Networking Break with Sponsors |
Session 2: Keeping up with New Paradigms in Neuro-Ophthalmology
|
|
| 1005– 1020 |
Case-based approach to optic disc edema |
| 1020– 1035 |
An update on Idiopathic Intracranial Hypertension |
| 1035– 1055 |
GRAHAM TROPE NAMED LECTURE: |
| 1055– 1115 |
SHERIF EL-DEFRAWY NAMED LECTURE: |
| 1115– 1130 |
Challenges in discerning AION from NAION: Atypical GCA |
| 1130– 1145 |
Immune check point inhibitors and emerging Neuro-Ophthalmic complications |
| 1145 – 1200 |
Session 2 – Q&A |
| 1200 – 100 |
Lunch Break and Networking with Sponsors |
Session 3: Eyelids and Anterior Segment Disease
|
|
| 100 – 115 |
Lid malpositions: ectropion, entropion, and trichiasis |
| 115 – 130 |
Approach to ptosis and new developments |
| 130 – 145 |
Lumps and bumps |
| 145 – 200 |
Anophthalmic socket |
| 200 – 220 |
Optimizing the Ocular Surface: The Interface Between Anterior Segment and Oculoplastic Surgeons |
| 220 – 230 |
Corneal neurotization |
| 230 – 245 |
Session 3 – Q&A |
| 245 – 315 |
Networking Break with Sponsors |
Session 4: Next Level Neuro-Ophthalmology Skills
|
|
| 315 – 330 |
Approach to diplopia |
| 330 – 345 |
The Afferent Pupillary Defect in Clinical Practice |
| 345 – 400 |
Management of Transient Visual Loss |
| 400 – 415 |
Approach to Facial and Eyelid spasms |
| 415 – 435 |
Differentiating Optic neuropathy from Retinal diseases and Glaucoma |
| 435 – 455 |
Case-based Neuro-ophthalmology Jeopardy |
| 455 – 510 |
Session 4 – Q&A |
| 510 |
Adjournment |